Compare Lemonade Inc (LMND) vs Strategy Inc. (MSTR) Price & Performance

Lemonade (LMND) trades at $67.47, up 0.43% on the day, with a bullish technical signal from moving averages and RSI near oversold levels. Revenue growth is accelerating, reaching $738 million in 2025, while net losses are narrowing to -$166 million. Recent news highlights expansion into new states and reinsurance program improvements, supporting optimism for future profitability.

The outlook is mixed: strong top-line growth and path to EBITDA positivity offer upside, but persistent losses and high valuation multiples pose risks. Analyst consensus targets $69.60, with 33% buy ratings, reflecting cautious optimism amid execution challenges in the competitive insurance sector.

MSTR trades at $97.77, up 3.08% today, but remains in a bearish technical trend with resistance at $98. The company shows concerning fundamentals with a -2,482% net income margin and negative cash flow from operations of -$67.24M in 2025. Recent earnings missed expectations in two of the last three quarters, though analyst consensus remains bullish with a $237.63 price target representing 143% upside potential from current levels.

While Wall Street maintains a Buy rating (62% of analysts), significant risks include extreme profitability challenges, volatile earnings history, and high debt levels. The stock's valuation appears disconnected from underlying business performance, trading at a low P/E of 5.3 but extremely high P/S of 57.4, suggesting investors are pricing in future growth that current operations don't support.